296 related articles for article (PubMed ID: 19813336)
1. [Treatment of lipid disorders in metabolic syndrome and type 2 diabetes. The place for fibrates].
Cybulska B; Kłosiewicz-Latoszek L
Kardiol Pol; 2005 Jun; 62 Suppl 2():II45-50. PubMed ID: 19813336
[No Abstract] [Full Text] [Related]
2. Role for fibrate therapy in diabetes: evidence before FIELD.
Vergès B
Curr Opin Lipidol; 2005 Dec; 16(6):648-51. PubMed ID: 16276243
[TBL] [Abstract][Full Text] [Related]
3. Management of cardiovascular risk associated with insulin resistance, diabetes, and the metabolic syndrome.
Mehta A
Postgrad Med; 2010 May; 122(3):61-70. PubMed ID: 20463415
[TBL] [Abstract][Full Text] [Related]
4. On the road to better dyslipidemia outcomes.
Hughes S
Nurse Pract; 2009 Feb; 34(2):14-21; quiz 22. PubMed ID: 19155874
[No Abstract] [Full Text] [Related]
5. The current unmet need in type 2 diabetes mellitus: addressing glycemia and cardiovascular disease.
Levy P
Postgrad Med; 2009 May; 121(3 Suppl 1):7-12. PubMed ID: 19494472
[TBL] [Abstract][Full Text] [Related]
6. Reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering: a role for fenofibrate. Introduction.
Sacks FM
Am J Cardiol; 2008 Dec; 102(12A):1L-3L. PubMed ID: 19084082
[No Abstract] [Full Text] [Related]
7. [Cardiometabolic high risk patients with abdominal obesity. Frequency and risk factor profile in primary care].
Scholze J; Lilienthal W; Bramlage P
MMW Fortschr Med; 2007 Sep; 149 Suppl 3():103-10. PubMed ID: 17955787
[TBL] [Abstract][Full Text] [Related]
8. Is it time to stop treating dyslipidaemia with fibrates?
Benatar JR; Stewart RA
N Z Med J; 2007 Sep; 120(1261):U2706. PubMed ID: 17853928
[TBL] [Abstract][Full Text] [Related]
9. Obesity and cardiometabolic syndrome in children.
Velasquez-Mieyer P; Neira CP; Nieto R; Cowan PA
Ther Adv Cardiovasc Dis; 2007 Oct; 1(1):61-81. PubMed ID: 19124396
[TBL] [Abstract][Full Text] [Related]
10. A review of the current status of the management of mixed dyslipidemia associated with diabetes mellitus and metabolic syndrome.
Davidson M
Am J Cardiol; 2008 Dec; 102(12A):19L-27L. PubMed ID: 19084086
[TBL] [Abstract][Full Text] [Related]
11. Metabolic syndrome: screening, diagnosis, and management.
Miller EL; Mitchell A
J Midwifery Womens Health; 2006; 51(3):141-51. PubMed ID: 16647666
[TBL] [Abstract][Full Text] [Related]
12. Lipid management in children.
Zappalla FR; Gidding SS
Endocrinol Metab Clin North Am; 2009 Mar; 38(1):171-83. PubMed ID: 19217518
[TBL] [Abstract][Full Text] [Related]
13. Metabolic syndrome: diabetes and cardiovascular disease.
Gupta S; Gupta BM
Indian Heart J; 2006; 58(2):149-52. PubMed ID: 18989060
[TBL] [Abstract][Full Text] [Related]
14. Solvay addresses unmet needs in the management of hypertensive patients with cardiometabolic and lipid disorders.
Cardiovasc J Afr; 2009; 20(1):73-4. PubMed ID: 19287821
[No Abstract] [Full Text] [Related]
15. Metabolic syndrome & obesity: co-epidemics could overwhelm home health care.
Pearce LC
Caring; 2003 Jun; 22(6):24-8, 30, 32-3; quiz 34-6. PubMed ID: 12905569
[TBL] [Abstract][Full Text] [Related]
16. Statin-fibrate combination therapy.
Feeman WE
Am J Cardiol; 2008 May; 101(10):1521. PubMed ID: 18471475
[No Abstract] [Full Text] [Related]
17. Mediterranean diet and metabolic diseases.
Giugliano D; Esposito K
Curr Opin Lipidol; 2008 Feb; 19(1):63-8. PubMed ID: 18196989
[TBL] [Abstract][Full Text] [Related]
18. Diabetic dyslipidemia and the heart.
Vasudevan AR; Garber AJ
Heart Fail Clin; 2006 Jan; 2(1):37-52. PubMed ID: 17386875
[No Abstract] [Full Text] [Related]
19. Behavioral interventions for obesity: recognizing our progress and future challenges.
Wing RR
Obes Res; 2003 Oct; 11 Suppl():3S-6S. PubMed ID: 14569033
[No Abstract] [Full Text] [Related]
20. Stemming the obesity-diabetes epidemic: lifestyle changes and therapeutics.
Schrier RW; Bogaert YE
Nat Clin Pract Nephrol; 2008 Sep; 4(9):486-7. PubMed ID: 18665143
[No Abstract] [Full Text] [Related]
[Next] [New Search]
